Gene-Tailored therapy shows promise for aggressive breast cancer
NCT ID NCT02624973
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving breast cancer treatment based on each tumor's unique genetic makeup works better than standard therapy. About 200 people with large or aggressive breast tumors will receive a personalized drug plan before surgery. Researchers will track how well the tumors shrink and look for genetic changes to guide future treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akershus University Hospital
Lørenskog, Akershus, Norway
-
Haukeland University Hospital
Bergen, Hordaland, 5021, Norway
-
Helse Fonna
Haugesund, Rogaland, Norway
-
Helse Førde
Førde, Sogn Og Fjordande, Norway
-
Helse Nord/UNN
Tromsø, Troms, Norway
-
Helse Stavanger
Stavanger, Rogaland, Norway
-
St. Olavs Hospital
Trondheim, Sør Trøndelag, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- A dab of gel on the breathing tube might spare surgery patients a sore throat — a trial puts it to the test.
- Can a deeper nerve block ease pain after breast surgery?
- Does breast cancer radiation harm a key immune gland? a study investigates
- A web program may ease the emotional toll of chemotherapy hair loss
- Can 3D breast imaging spot more dangerous cancers than standard mammograms?